Patent · US Active

Substituted [1,2,4]triazolo[4′,3′:1,6]pyrido[2,3-b]pyrazines of the formula D

US8207169B2 · kind B2 · utility

4Cited by
1References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 28, 2009
Grant dateJun 26, 2012
Priority date
Expiry dateMay 28, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The compounds of Formula D are of the class of triazolo-pyrido-pyrazines which are inhibitors of AKT useful for the treatment of cancer

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.